Valuation: Adocia

Market Cap 74.62M 85.2M 68.87M 63.63M 121M 8.15B 123M 826M 321M 4B 320M 313M 13.85B P/E 2026 *
15.4x
P/E 2027 * 7.65x
Enterprise Value 44.78M 51.13M 41.32M 38.18M 72.44M 4.89B 73.76M 496M 193M 2.4B 192M 188M 8.31B EV / Sales 2026 *
3.58x
EV / Sales 2027 * 3.25x
Free-Float
89.7%
Yield 2026 *
-
Yield 2027 * -
1 day-3.93%
1 week-7.87%
Current month-7.87%
1 month-10.89%
3 months-12.64%
6 months-37.98%
Current year-43.07%
1 week 3.73
Extreme 3.732
4.53
1 month 3.73
Extreme 3.732
4.71
Current year 3.73
Extreme 3.732
7.45
1 year 3.73
Extreme 3.732
12.4
3 years 2.86
Extreme 2.86
16.16
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
62.9
Manager TitleAgeSince
Chief Executive Officer 55 2023-05-10
Director of Finance/CFO - 2024-09-22
Chief Tech/Sci/R&D Officer - 2014-11-30
Director TitleAgeSince
Director/Board Member 55 2013-04-18
Chairman 80 2012-02-23
Director/Board Member 58 2013-06-17
Date Insider Type Main position Quantity % Market Cap.
25-02-26Buy

Founder

109,170 0.6972%
24-04-05Buy

Founder

15,576 0.1105%
24-04-05Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
-3.93%-7.87%+3.92%-18.94% 88.76M
-1.53%-1.43%+71.67%+129.70% 57.72B
-2.45%-7.32%+65.23%+83.15% 52.65B
+3.27%+9.29%+20.20%+486.76% 24.46B
-0.81%+0.52%-15.01%-12.47% 23.84B
-3.05%+3.06%+42.36%-5.66% 19.28B
-0.24%+5.40%+44.65%-26.41% 17.8B
+2.34%+14.18%+220.96%+380.99% 17.29B
-6.73%+9.90%+36.04% - 15.28B
-1.70%+3.12%+27.06%+190.57% 14.35B
Average -1.48%+4.27%+51.71%+134.19% 24.28B
Weighted average by Cap. -1.26%+2.70%+57.99%+141.60%

Financials

2026 *2027 *
Net sales 12.5M 14.27M 11.54M 10.66M 20.22M 1.36B 20.59M 138M 53.82M 670M 53.56M 52.41M 2.32B 32.26M 36.83M 29.77M 27.5M 52.18M 3.52B 53.13M 357M 139M 1.73B 138M 135M 5.99B
Net income -518K -591K -478K -442K -838K -56.54M -853K -5.73M -2.23M -27.75M -2.22M -2.17M -96.11M -47.3M -54.01M -43.65M -40.33M -76.52M -5.17B -77.92M -524M -204M -2.53B -203M -198M -8.78B
Net Debt -29.84M -34.07M -27.54M -25.45M -48.27M -3.26B -49.16M -330M -128M -1.6B -128M -125M -5.54B 30.18M 34.45M 27.85M 25.73M 48.81M 3.29B 49.7M 334M 130M 1.62B 129M 127M 5.6B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Date Price Change Volume
26-07-08 €3.814 -3.93% 216,370
26-07-07 €3.970 -6.15% 213,568
26-07-06 €4.230 -5.03% 259,816
26-07-03 €4.454 +4.07% 233,415
26-07-02 €4.280 +2.74% 181,310
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.814EUR
Average target price
10.70EUR
Spread / Average Target
+180.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock